2.56
-0.05 (-1.92%)
-0.05 (-1.92%)
Upgrade to Real-Time
Regular Market
Low
2.15
High
6.25
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Galmed Pharmaceuticals Ltd | GLMD | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.05 | -1.92% | 2.56 | 13:47:23 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.65 | 2.54 | 2.67 | 2.61 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 2.55 | 2.58 | 0.03 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 269 | 59,179 | $ 2.59 | $ 153,568 | - | 2.15 - 6.25 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:48:51 | 1 | $ 2.55 | USD |
Period:
Draw Mode:
Galmed Pharmaceuticals Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 54.05M | 21.11M | 17.58M | $ - | $ - | -0.57 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | - |
Galmed Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GLMD Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.52 | 2.83 | 2.51 | 2.66 | 77,780 | 0.04 | 1.59% |
| 1 Month | 3.15 | 3.29 | 2.51 | 2.93 | 108,450 | -0.59 | -18.73% |
| 3 Months | 3.30 | 4.08 | 2.15 | 3.13 | 289,978 | -0.74 | -22.42% |
| 6 Months | 3.9797 | 6.25 | 2.15 | 3.83 | 346,896 | -1.42 | -35.67% |
| 1 Year | 4.52 | 6.25 | 2.15 | 3.81 | 221,929 | -1.96 | -43.36% |
| 3 Years | 14.35 | 14.6495 | 2.15 | 5.69 | 145,260 | -11.79 | -82.16% |
| 5 Years | 4.2101 | 27.06 | 2.15 | 8.33 | 145,593 | -1.65 | -39.19% |
Galmed Pharmaceuticals Description
| Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis. |
